These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 31332994)
1. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients. Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994 [TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis. Sayed SK; Galal SH; Herdan OM; Mahran AM Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349 [TBL] [Abstract][Full Text] [Related]
3. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus. Yuan Y; Yang M; Wang K; Sun J; Song L; Diao X; Jiang Z; Cheng G; Wang X Arthritis Res Ther; 2017 Mar; 19(1):70. PubMed ID: 28356164 [TBL] [Abstract][Full Text] [Related]
4. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus. Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025 [TBL] [Abstract][Full Text] [Related]
5. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
6. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis. Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients. He D; Liu M; Liu B Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis. Hammad AM; Youssef HM; El-Arman MM Lupus; 2006; 15(9):608-12. PubMed ID: 17080918 [TBL] [Abstract][Full Text] [Related]
10. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus. Hafez EA; Hassan SAE; Teama MAM; Badr FM Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012 [TBL] [Abstract][Full Text] [Related]
11. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis. Xing Q; Su H; Cui J; Wang B Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis. Manolova I; Gerenova J; Ivanova M Eur Cytokine Netw; 2013 Mar; 24(1):69-74. PubMed ID: 23614931 [TBL] [Abstract][Full Text] [Related]
13. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA; El-Gendi HI; Ahmed HH Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [TBL] [Abstract][Full Text] [Related]
14. Serum thiols as a biomarker of disease activity in lupus nephritis. Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079 [TBL] [Abstract][Full Text] [Related]
15. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis. Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273 [TBL] [Abstract][Full Text] [Related]
16. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis. Abdel-Wahab AF; Fathy O; Al-Harizy R Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228 [TBL] [Abstract][Full Text] [Related]
17. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study. Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis. Soliman WM; Sherif NM; Ghanima IM; El-Badawy MA Reumatol Clin (Engl Ed); 2020; 16(4):255-261. PubMed ID: 30166230 [TBL] [Abstract][Full Text] [Related]
20. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study. Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]